These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11924906)

  • 1. Death receptor ligands in tumors.
    Cappello P; Novelli F; Forni G; Giovarelli M
    J Immunother; 2002; 25(1):1-15. PubMed ID: 11924906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages.
    Kaplan MJ; Ray D; Mo RR; Yung RL; Richardson BC
    J Immunol; 2000 Mar; 164(6):2897-904. PubMed ID: 10706675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.
    Inman GJ; Allday MJ
    J Immunol; 2000 Sep; 165(5):2500-10. PubMed ID: 10946276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.
    Almasan A; Ashkenazi A
    Cytokine Growth Factor Rev; 2003; 14(3-4):337-48. PubMed ID: 12787570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumoricidal activity of monocyte-derived dendritic cells: evidence for a caspase-8-dependent, Fas-associated death domain-independent mechanism.
    Vanderheyde N; Aksoy E; Amraoui Z; Vandenabeele P; Goldman M; Willems F
    J Immunol; 2001 Oct; 167(7):3565-9. PubMed ID: 11564767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
    Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
    J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis control by death and decoy receptors.
    Ashkenazi A; Dixit VM
    Curr Opin Cell Biol; 1999 Apr; 11(2):255-60. PubMed ID: 10209153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.
    Gong B; Almasan A
    Cancer Res; 2000 Oct; 60(20):5754-60. PubMed ID: 11059770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.
    Sprick MR; Rieser E; Stahl H; Grosse-Wilde A; Weigand MA; Walczak H
    EMBO J; 2002 Sep; 21(17):4520-30. PubMed ID: 12198154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
    J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple pathways of TWEAK-induced cell death.
    Nakayama M; Ishidoh K; Kayagaki N; Kojima Y; Yamaguchi N; Nakano H; Kominami E; Okumura K; Yagita H
    J Immunol; 2002 Jan; 168(2):734-43. PubMed ID: 11777967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
    Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
    Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells.
    Kaplan MJ; Lewis EE; Shelden EA; Somers E; Pavlic R; McCune WJ; Richardson BC
    J Immunol; 2002 Nov; 169(10):6020-9. PubMed ID: 12421989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
    Peták I; Houghton JA
    Pathol Oncol Res; 2001; 7(2):95-106. PubMed ID: 11458271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
    Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kiss of death: promises and failures of death receptors and ligands in cancer therapy.
    Daniel PT; Wieder T; Sturm I; Schulze-Osthoff K
    Leukemia; 2001 Jul; 15(7):1022-32. PubMed ID: 11455969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.